Section Reviews: Biologicals & Immunologicals: Extracellular matrix components and their receptors as targets for therapeutic intervention in inflammation and metastasis

References to Primarv Literature

• SPRINGER TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.Cell (1994) 76:301–314.
   Google Scholar
• NATHAN C, SRIMAL S, FARBER C et at.: Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 inte-grins. J. Cell Biol. (1989) 109:1341–1349.
   Google Scholar
• EIERMAN DF, JOHNSON CE, HASKILL JS: Human mono-cyte inflammatory mediator gene expression is selec-tively regulated by adherence substrates. J. Immunot (1989) 142:1970–1976.
   Google Scholar
• REICFIARDT LF, TOMASELLI KJ: Extracellular matrix molecules and their receptors: functions in neural development. Ann. Rev. Neurosci. (1991) 14:531–570.
   PubMed Web of Science ®Google Scholar
• HYNES RO: Integrins: versatility, modulation and signalling in cell adhesion. Cell (1992) 69:11–25.
   Google Scholar
• KASAHARA K, STRIETER RM, STANDIFORD TJ, KUNKEL SL: Adherence in combination with lipopolysaccharide, tumor necrosis factor or interleukin-1 beta potentiates the induction of monocyte-derived interleukin-8. Pathobiology (1993) 61:57–66.
   PubMed Web of Science ®Google Scholar
• PAKIANATHAN DR: Extracellular matrix proteins and leukocyte function. J. Leuk. Biol. (1995) 57:699–702.
   Google Scholar
• PACIFICI R, BASILIC° C, ROMAN J et al.: Collagen-induced release of Interleukin 1 from human blood mononu-clear cells. J. Clin. Invest. (1992) 89:61–67.
   Google Scholar
• HYNES RO, YAMADA KM: Fibronectins: multifunctional modular glycoproteins. J. Cell Biol. (1982) 95:369–377.
   PubMed Web of Science ®Google Scholar
• RUOSLAHTI E, YAMAGUCHI Y: Proteoglycans as modu-lators of growth factor activities. Cell (1991) 64:867–869.
   PubMed Web of Science ®Google Scholar
• RUOSLAHTI E, YAMAGUCHI Y: Extracellular matrixd growth factor interactions. Cold Spring Harb. Symp. Quant. Biol. (1992) 57:309–315.
   Google Scholar
• WEBB LM, EHRENGRUBER MU, CLARK-LEWIS I, BAG- •GIOLINI M, ROT A: Binding to heparan sulfate or heparin enhances neutrophll responses to interleukin 8. Proc. Natl. Acad. Sci. USA. (1993) 90:7158–7162.
   Google Scholar
• BEVILACQUA MP: Endothelial-Leukocyte adhesion molecules. Ann. Rev. Immunot (1993) 11:767–804.
   Google Scholar
• RUOSLAHTI E, PIERSCHBACHER MD: New perspectives incell adhesion: RGD and integrins. Science (1987) 238:491–497.
   PubMed Web of Science ®Google Scholar
• RUOSLAHTI E: Integrins. J. Clin. Invest. (1991) 87:1–5.
   Google Scholar
• HEMLER ME: VIA proteins in the integrin family: struc-tures, function and their role on leukocytes. Ann. Rev. Immunot (1990) 8:365–400.
   PubMed Web of Science ®Google Scholar
• ALTIERI DC, BADER R, MANNUCCI PM, EDGINGTON TS: Oligospecllicity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen.]. Cell Biol. (1988) 107:1893–1900.
   PubMed Web of Science ®Google Scholar
• SHIMIZU Y, SEVENTER GAV, HORGAN KJ, SHAW S: Regu-lated expression and binding of three VLA integrin receptors on T cells. Nature (1990) 345:250–253.
   PubMed Web of Science ®Google Scholar
• TACHIBANA K, SATO T, D'AVIRRO N, MORIMOTO C: Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp 12 5FAK. J. Exp . Med. (1995) 182:1089–1099.
   PubMed Web of Science ®Google Scholar
• ENGVALL E, RUOSLAHTI E: Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer (1977) 20:1–5.
   PubMed Web of Science ®Google Scholar
• KASAHARA K, STRIETER RM, CHENSUE SW, STANDIFORD TJ, KUNKEL SL: Mononudear cell adherence induces neutrophil chemotactic factor/Interleukin 8 gene ex-pression_ j Leuk. Biol. (1991) 50:287–295.
   Google Scholar
• NATHAN C: Neutrophil activation on biological sur-faces. J. Clin. Invest. (1987) 80:1550–1560.
   PubMed Web of Science ®Google Scholar
• FOLKMAN J, WATSON K, INGBER D, HANAHAN D: Induc-tion of angiogenesis during the transition from hyper-plasia to neoplasia. Nature (1989) 339:58–61.
   PubMed Web of Science ®Google Scholar
• GO 11LSMAN M: The role of proteases in cancer. Seinin. Cancer Biol. (1990) 1:97–160.
   Google Scholar
• MARX J: Learning how to suppress cancer. Science (1993) •261:1385-1387.
   Google Scholar
• SLAMON DJ, CLARK GM, WONG S et al.: Human breast cancer: correlation of relapse and survival with ampli-fication of the HER-2/neu oncogene. Science (1987) 235:177–182.
   PubMed Web of Science ®Google Scholar
• KWAAN HC: The plasminogen-plasmin system in malig-nancy. Cancer Metastasis Rev. (1992) 11:291–311.
   PubMed Web of Science ®Google Scholar
• BASSET P, BELLOCQ JP, WOLF C et al.: A novel metallo-proteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (1990) 348:699–704.
   PubMed Web of Science ®Google Scholar
• BROWN PD, LEVY AT, MARGUILES I, LIOTTA L, STETLER-STEVENSON WG: Independent expression and cellular processing of the 72 kDa type IV collagenase and Interstitial collagenase in human tumorigenic cell lines. Cancer Res. (1990) 50:6184–6191.
   PubMed Web of Science ®Google Scholar
• SLOANE BR, HONN KV: Cysteine proteinases and metas-tasis. Cancer Metastasis Rev. (1984) 3:249.
   PubMed Web of Science ®Google Scholar
• ROZHIN J, SAMENI M, ZIEGLER G, SLOANE BE: Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. (1994) 54:6517–6525.
   PubMed Web of Science ®Google Scholar
• FRISCH SM, FRANCIS H: Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Blot (1994) 124:619–626.
   PubMed Web of Science ®Google Scholar
• GUIRGLI1S R, MARGUILES IMK, TARABOLE1TI G: Cytokineinduced pseudopodial protrusion is coupled to tumor cell migration. Nature (1987) 329:261.
   PubMed Web of Science ®Google Scholar
• HOTTA L: Tumor invasion and metastasis-role of theextraceLlular matrix: Rhoads Memorial Award Lecture. Cancer Res. (1986) 43:1.
   Google Scholar
• KRUSLUS T, RUOSLAITTI E: Primary structure of an ex-tracellular matrix proteog,lycan core protein deduced from cloned DNA. Proc. Nall. Acad. Sci, USA (1986) 83:7683–7687.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI Y, RUOSLAIITI E: Expression of human proteoglycan on chinese hamster ovary cells inhibits cell proliferation. Nature (1988) 336:244–246.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI Y, MANN DM, RUOSLAHTI E: Negative regu-lation of transforming growth factor-beta by the pro-teoglycan decorin. Nature (1990) 346:281–284.
   PubMed Web of Science ®Google Scholar
• ISAKA Y, BREES DK, IKEGAYA K et al.: Gene therapy by skeletal muscle expression of decorin prevents fibroticdisease in rat kidney. Nature Medicine (1996) 2:418–423.
   Google Scholar
• MAUVLEL A, SANTRA M, CIIEN YO, urrTo J, IZZO RV: •Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumour necrosis factor-alpha. J. Biol. Chem. (1995) 270:11692–11700.
   Google Scholar
• HARALSON MA, HASSEL JR: The extracellular matrix-anoverview. In: Extracellular Matrix: A Practical Approach. Haralson MA, Hassell JR (Eds.), IRL Press (1995)1–30.
   Google Scholar
• MIAO HQ, ISHAI-MICHAELI R, PERETZ T, VLODAVSKY I:
   Google Scholar
• Larninarin sulfate mimics the effects of heparin onsmooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity. J. Cell Physiol. (1995) 164:482–490.
   Google Scholar
• TREMBLE P, CHIQUET-EHRISMANN R, WERB Z: The ex- tracellular matrix ligands fibronectin and tenascin col-laborate in regulating collagenase gene expression in fibroblasts. Mol. Biol. Cell (1994) 5:439–453.
   Google Scholar
• GOETZL EJ, BANDA MJ, LEPPERT D: Matrix metalloproteinases in immunity. J. Immunol. (1996) 156:1–4.
   Google Scholar
• BIRKEDAL-HANSEN H: Proteolytic remodelling of the extracellular matrix. Curr. Opin. Cell Biol. (1995) 7:728–735.
   Google Scholar
• PALMER JT, RASNICK D, KLAUS JL, BROMME D: Vinyl sulfones as mechanism based cysteine protease inhibi-tors. J. Med. Chem. (1995) 38:3193–3196.
   Google Scholar
• LOBB RR, HEMLER ME: The pathophysiological role of alpha 4 integrisis in vivo. J. Clin. Invest. (1994) 94:1722–1728.
   Google Scholar
• SHYJAN AM, BERTAGNOLLI M, KENNEY CJ, BRISKIN MJ:
   Google Scholar
• •Human mucosal addressin cell adhesion molecule-1 (MadCAM-1) demonstrates structural and functional similarities to the alpha4beta7-integrin binding do-mains of murine MadCAM-1 but extreme divergence of mucin-like sequences. J ImmunoL (1996) 156:2851–2857.
   PubMed Web of Science ®Google Scholar
• MOYLE M, FOSTER DL, MCGRATH DE et al.: A hookworm glycoprotein that inhibits neutrophll function is a li-gand of the integrin CD1 lb/CD18. (1994).
   Google Scholar
• PIGUET PF, TACCHINI-COTTIER F, VESIN C: Administration of anti-TNF-alpha or anti-CD 11a antibodies to nor-mal adult mice decreases lung and bone collagen content. Am. J. Respir. Cell Mol. Biol. (1995) 12:227–231.
   Google Scholar
• PALMADE F, SECHOY-CHAMBON O, VAINS JBRD, CO-
   Google Scholar
• QUELET C, BONNE C: Inhibition of cell adhesion to lenscapsule by LCM 1910, an RGD-derived peptide. J. Ocul. Pharmacol. (1994) 10:623–632.
   Google Scholar
• UENO M, AMEMIYA M, SOMENO T et al.: IC101, extracellular matrix antagonist produced by Streptomyces sp. MJ 202-72F3. Production, isolation, structure determination and biological activity. J. Antibiot. (Tokyo) (1993) 46:1658–1665.
   Google Scholar
• AMEMIYA M, SOMENO T, SAWA R et al.: Cytostatin, a sonovel inhibitor of cell adhesion to components ofextraceffular matrix produced by Streptomyces sp. MJ654-NF4. IL Physico-chemical properties and struc-ture determination. J. Antibiot. (Tokyo) (1994) 47:541–544.
   Google Scholar
• YAMAZAKI K, AMEMIYA M, ISHIZUKA M, TAKEUCHI T: •Screening for apoptosis inducers in microbial products and induction of apoptosis by cytostatin. J. Antibiot. (Tokyo) (1995) 48:1138–1140.
   Google Scholar
• SAIKI I, YONEDA J, KOBAYASHI H et al.: Anti-metastatic effect by anti-adhesion therapy with cell-adhesive pep-tide of fibronectin in combination with anti-cancer drugs. Jpn. J. Cancer Res. (1993) 84:326–335.
   Google Scholar
• YONEDA J, SALKI I, KOBAYASHI II et al.: Inhibitory effect of recombinant fibronectin polypeptides on the adhe-sion of liver-metastatic lymphoma cells to hepatic sinusoidal endothelial cells and tumor invasion. Jpn. J. Cancer Res. (1994) 85:723–734.
   Google Scholar
• BROOKS PC, STROMBLAD S, KLEMKE R et at.: Anti-integrin alpha vs beta 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. (1995) 96:1815–1822.
   Google Scholar
• BROOKS PC, MONTGOMERY AM, ROSENFELD M et al.:
   Google Scholar
• •Integrin alpha vs beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell (1994) 79:1157–1164.
   PubMed Web of Science ®Google Scholar
• STUTTER RM, POLVERINI PJ, ARENBERG DA, KUNKEL SL: •The role of CXC chemokines as regulators of angiogene-sis. Shock (1995) 4:155–160.
   Google Scholar
• BAR-SHAVIT R, GINZBERG Y, MAOZ M, VLODAVSKY I, PERETZ T: The involvement of thrombin RGD in metas-tasis: characterization of a cryptic site. Isr. J. Med. Sci. (1995) 31:86–94.
   Google Scholar